Seeking Alpha

Pozen (POZN) -24.7% premarket after the biotech company discloses the FDA requested additional...

Pozen (POZN) -24.7% premarket after the biotech company discloses the FDA requested additional data for its PA32540 fixed-dose "safer aspirin" product which may delay submission of its new drug application.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)